FDA — authorised 14 June 1965
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
🇺🇸 Maolate in United States
FDA authorised Maolate on 14 June 1965
Marketing authorisations
FDA — authorised 14 June 1965
- Application: NDA014217
- Marketing authorisation holder: PAMLAB LLC
- Local brand name: MAOLATE
- Indication: TABLET — ORAL
- Status: approved
Maolate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Maolate approved in United States?
Yes. FDA authorised it on 14 June 1965; FDA authorised it on 14 June 1965.
Who is the marketing authorisation holder for Maolate in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.